Variant report

Variant	nsv960076
Chromosome Location	chr17:20610812-20689633
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:248)
CpG islands
(count:550)
Chromatin interactive
region (count:10)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:248 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr17:20637414-20637538	K562	blood:	n/a	n/a
2	BCL3	chr17:20674472-20674782	GM12878	blood:	n/a	n/a
3	BCL3	chr17:20674383-20674846	GM12878	blood:	n/a	n/a
4	CEBPB	chr17:20672431-20672674	K562	blood:	n/a	chr17:20672562-20672573
5	CEBPB	chr17:20614479-20614538	K562	blood:	n/a	n/a
6	CEBPB	chr17:20624556-20624832	A549	lung:	n/a	n/a
7	CEBPB	chr17:20625585-20625841	HepG2	liver:	n/a	chr17:20625724-20625737
8	CEBPB	chr17:20624537-20624839	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr17:20621783-20621875	A549	lung:	n/a	n/a
10	CEBPB	chr17:20672466-20672706	HepG2	liver:	n/a	chr17:20672562-20672573
11	CTCF	chr17:20682959-20683051	K562	blood:	n/a	n/a
12	CTCF	chr17:20682923-20683126	H1-hESC	embryonic stem cell:	n/a	n/a
13	CTCF	chr17:20662800-20662950	HCM	heart:	n/a	n/a
14	CTCF	chr17:20688552-20688651	GM20000	blood:	n/a	n/a
15	CTCF	chr17:20682880-20683030	HCT-116	colon:	n/a	n/a
16	CTCF	chr17:20662860-20663010	HVMF	connective:	n/a	n/a
17	CTCF	chr17:20662820-20662970	MCF-7	breast:	n/a	n/a
18	CTCF	chr17:20672308-20672397	GM12891	blood:	n/a	n/a
19	CTCF	chr17:20662999-20663023	MCF-7	breast:	n/a	n/a
20	CTCF	chr17:20662840-20662990	SAEC	small airway:	n/a	n/a
21	CTCF	chr17:20685497-20685535	GM10266	blood:	n/a	n/a
22	CTCF	chr17:20662840-20662990	GM12869	blood:	n/a	n/a
23	CTCF	chr17:20662511-20662615	Fibrobl	skin:	n/a	n/a
24	CTCF	chr17:20670084-20670101	MCF-7	breast:	n/a	n/a
25	CTCF	chr17:20662964-20663018	MCF-7	breast:	n/a	n/a
26	CTCF	chr17:20682920-20683150	HCT-116	colon:	n/a	n/a
27	CTCF	chr17:20682962-20683061	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr17:20662966-20663046	MCF-7	breast:	n/a	n/a
29	CTCF	chr17:20682928-20683099	MCF-7	breast:	n/a	n/a
30	CTCF	chr17:20682918-20683105	MCF-7	breast:	n/a	n/a
31	CTCF	chr17:20662840-20662990	HVMF	connective:	n/a	n/a
32	CTCF	chr17:20682928-20683064	MCF-7	breast:	n/a	n/a
33	CTCF	chr17:20674300-20674450	NHEK	skin:	n/a	n/a
34	CTCF	chr17:20682935-20683060	NHEK	skin:	n/a	n/a
35	CTCF	chr17:20662976-20663012	H1-hESC	embryonic stem cell:	n/a	n/a
36	CTCF	chr17:20683080-20683230	MCF-7	breast:	n/a	n/a
37	CTCF	chr17:20682952-20683057	Gliobla	brain:	n/a	n/a
38	CTCF	chr17:20662820-20662970	GM12872	blood:	n/a	n/a
39	CTCF	chr17:20682925-20683108	MCF-7	breast:	n/a	n/a
40	CTCF	chr17:20685491-20685494	GM10266	blood:	n/a	n/a
41	CTCF	chr17:20682982-20683053	HepG2	liver:	n/a	n/a
42	CTCF	chr17:20683100-20683250	NHEK	skin:	n/a	n/a
43	CTCF	chr17:20662880-20663030	GM12873	blood:	n/a	n/a
44	CTCF	chr17:20682924-20683099	MCF-7	breast:	n/a	n/a
45	CTCF	chr17:20682965-20683039	GM12891	blood:	n/a	n/a
46	CTCF	chr17:20643656-20643723	GM10248	blood:	n/a	n/a
47	CTCF	chr17:20662539-20662604	GM10248	blood:	n/a	n/a
48	CTCF	chr17:20626441-20626497	GM13977	blood:	n/a	n/a
49	CTCF	chr17:20621422-20621493	GM13977	blood:	n/a	n/a
50	CTCF	chr17:20662860-20663010	HEK293	kidney:	n/a	n/a

(count:550 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20687912-20687962	GM12892	blood:	n/a
2	chr17:20687912-20687962	GM12892	blood:	n/a
3	chr17:20687681-20687731	HCM	heart:	n/a
4	chr17:20687912-20687962	HRE	kidney:	n/a
5	chr17:20687481-20687531	ovcar-3	ovarian:	n/a
6	chr17:20688483-20688533	H1-hESC	embryonic stem cell:	embryo
7	chr17:20687681-20687731	BE2_C	brain:	n/a
8	chr17:20687912-20687962	Caco-2	colon:	n/a
9	chr17:20688483-20688533	SK-N-SH	brain:	n/a
10	chr17:20687698-20687748	HUVEC	blood vessel:	n/a
11	chr17:20688483-20688533	HL-60	blood:	n/a
12	chr17:20687912-20687962	NH-A	brain:	n/a
13	chr17:20688483-20688533	K562	blood:	n/a
14	chr17:20688483-20688533	AG04450	lung:	fetal
15	chr17:20687481-20687531	AG09309	skin:	n/a
16	chr17:20687681-20687731	SKMC	muscle:	n/a
17	chr17:20688701-20688751	MCF10A-Er-Src	breast:	n/a
18	chr17:20688701-20688751	AG04450	lung:	fetal
19	chr17:20687912-20687962	Hela-S3	cervix:	n/a
20	chr17:20687698-20687748	HEK293	kidney:	embryo
21	chr17:20687481-20687531	Hepatocyte	liver:	n/a
22	chr17:20688483-20688533	MCF-7	breast:	n/a
23	chr17:20683924-20683974	HPAEpiC	pulmonary alveolar:	n/a
24	chr17:20687681-20687731	AG09309	skin:	n/a
25	chr17:20683924-20683974	K562	blood:	n/a
26	chr17:20683924-20683974	HIPEpiC	eye:	n/a
27	chr17:20687481-20687531	NB4	blood:	n/a
28	chr17:20683924-20683974	HCM	heart:	n/a
29	chr17:20688483-20688533	HNPCEpiC	eye:	n/a
30	chr17:20683924-20683974	PFSK-1	brain:	n/a
31	chr17:20688701-20688751	MCF-7	breast:	n/a
32	chr17:20687912-20687962	AG04450	lung:	fetal
33	chr17:20687681-20687731	ProgFib	skin:	n/a
34	chr17:20687761-20687811	GM19239	blood:	n/a
35	chr17:20687761-20687811	AG09309	skin:	n/a
36	chr17:20687912-20687962	HPAEpiC	pulmonary alveolar:	n/a
37	chr17:20687761-20687811	SK-N-SH_RA	brain:	n/a
38	chr17:20687698-20687748	HAEpiC	amniotic membrane:	n/a
39	chr17:20688701-20688751	RPTEC	kidney:	n/a
40	chr17:20683924-20683974	AG09309	skin:	n/a
41	chr17:20687681-20687731	RPTEC	kidney:	n/a
42	chr17:20688522-20688572	Jurkat	blood:	n/a
43	chr17:20688701-20688751	LNCaP	prostate:	n/a
44	chr17:20688483-20688533	MCF10A-Er-Src	breast:	n/a
45	chr17:20687912-20687962	AG09319	gingival:	n/a
46	chr17:20688483-20688533	HRCEpiC	kidney:	n/a
47	chr17:20687698-20687748	H1-hESC	embryonic stem cell:	embryo
48	chr17:20688701-20688751	T-47D	breast:	n/a
49	chr17:20687681-20687731	AoSMC	blood vessel:	n/a
50	chr17:20687681-20687731	HEK293	kidney:	embryo

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:20651225..20652727-chr17:58034005..58036459,2	MCF-7	breast:
2	chr17:20639441..20641960-chr17:20642430..20644326,2	K562	blood:
3	chr17:20689022..20691056-chr17:20693730..20696703,2	K562	blood:
4	chr17:20610050..20610947-chr17:30454022..30454629,2	Hela-S3	cervix:
5	chr17:20647874..20648866-chr17:58031160..58032144,3	MCF-7	breast:
6	chr17:20639441..20641960-chr17:20642430..20644326,2	K562	blood:
7	chr17:20646890..20651186-chr17:58030459..58033432,3	MCF-7	breast:
8	chr17:20640004..20640962-chr17:58024195..58025007,2	MCF-7	breast:
9	chr17:20649688..20651234-chr17:58034050..58037704,4	MCF-7	breast:
10	chr17:20649661..20650164-chr17:58032683..58033398,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CDRT15L2-5	chr17:20678955-20680218	NONHSAT146832
2	lnc-CCDC144NL-5	chr17:20674371-20674740	NONHSAT146831

No data

Variant related genes	Relation type
ENSG00000264874	TF binding region
HNRNPA1P19	TF binding region
OLA1P2	TF binding region
SCDP1	TF binding region
ENSG00000226521	TF binding region
ENSG00000264215	TF binding region
RNFT1P3	TF binding region
ENSG00000264874	CpG island
HNRNPA1P19	CpG island
OLA1P2	CpG island
SCDP1	CpG island
ENSG00000226521	CpG island
ENSG00000264215	CpG island
RNFT1P3	CpG island
ENSG00000189050	chromatin interactions
ENSG00000108443	chromatin interactions

Extended variants
information (count: 1548 )
Associated
traits (count: 152 )

Variant overlapped rSNPs/rCNVs (count:1548 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs530035167	chr17:20610819-20610820	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs181308900	chr17:20610843-20610844	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs73981792	chr17:20610853-20610854	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs527759873	chr17:20610901-20610902	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs552737795	chr17:20610906-20610907	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs570933452	chr17:20610934-20610935	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs531976603	chr17:20610935-20610936	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs377359570	chr17:20610947-20610948	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs550195959	chr17:20610951-20610952	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs367754869	chr17:20611009-20611010	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs568695987	chr17:20611047-20611048	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs149710525	chr17:20611063-20611064	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs146763319	chr17:20611068-20611069	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs370295405	chr17:20611072-20611073	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs140436456	chr17:20611080-20611081	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs145545692	chr17:20611085-20611086	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs185668359	chr17:20611086-20611087	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs146437472	chr17:20611150-20611151	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs149032972	chr17:20611154-20611155	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs190044222	chr17:20611164-20611165	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs111647401	chr17:20611176-20611177	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs111396980	chr17:20611199-20611200	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs113186582	chr17:20611233-20611234	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs111232163	chr17:20611250-20611251	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs111673032	chr17:20611267-20611268	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs544437974	chr17:20611271-20611272	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs182754582	chr17:20611273-20611274	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs574630691	chr17:20611278-20611279	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs111315134	chr17:20611288-20611289	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs542168826	chr17:20611292-20611293	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs113582566	chr17:20611293-20611294	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs188921324	chr17:20611319-20611320	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs528445940	chr17:20611400-20611401	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs560486001	chr17:20611417-20611418	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs551504357	chr17:20611419-20611420	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs192353085	chr17:20611436-20611437	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs571395832	chr17:20611493-20611494	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs564642175	chr17:20611571-20611572	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs531721790	chr17:20611575-20611576	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs550302448	chr17:20611607-20611608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs114267739	chr17:20611614-20611615	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs529509312	chr17:20611615-20611616	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs148208704	chr17:20611641-20611642	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs547719856	chr17:20611672-20611673	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs566110807	chr17:20611734-20611735	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs533590124	chr17:20611747-20611748	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs551162873	chr17:20611769-20611770	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs141529149	chr17:20611775-20611776	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs147080396	chr17:20611785-20611786	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs537550792	chr17:20611797-20611798	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:152)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	17142309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:74 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20609400-20614800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
2	chr17:20610800-20611000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
3	chr17:20610800-20611000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
4	chr17:20610800-20611000	Enhancers	Hela-S3	cervix
5	chr17:20614800-20615000	Enhancers	Primary hematopoietic stem cells short term culture	blood
6	chr17:20615000-20615400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
7	chr17:20615400-20615800	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr17:20624000-20625000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr17:20624000-20625000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
10	chr17:20624200-20625000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr17:20624600-20625000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr17:20626600-20626800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr17:20628200-20631200	Enhancers	Primary B cells from peripheral blood	blood
14	chr17:20628400-20629200	Enhancers	GM12878-XiMat	blood
15	chr17:20640200-20640400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
16	chr17:20640400-20641400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
17	chr17:20641400-20641600	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
18	chr17:20641400-20642400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr17:20641600-20642000	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
20	chr17:20651600-20651800	Bivalent Enhancer	Hela-S3	cervix
21	chr17:20665400-20687200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr17:20666800-20667000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
23	chr17:20667000-20667200	ZNF genes & repeats	Right Atrium	heart
24	chr17:20667000-20667400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr17:20667200-20668400	Weak transcription	Right Atrium	heart
26	chr17:20677400-20678000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr17:20677600-20678200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr17:20677800-20679200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr17:20678000-20678600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr17:20678200-20678600	Enhancers	Muscle Satellite Cultured Cells	--
31	chr17:20678200-20678600	Enhancers	Brain Inferior Temporal Lobe	brain
32	chr17:20678200-20679000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr17:20678200-20679000	Enhancers	Osteobl	bone
34	chr17:20678200-20679400	Enhancers	Adipose Nuclei	Adipose
35	chr17:20678600-20679400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr17:20678800-20679200	Enhancers	Fetal Muscle Leg	muscle
37	chr17:20679000-20679200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr17:20679200-20682000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr17:20681600-20684000	Enhancers	Primary monocytes fromperipheralblood	blood
40	chr17:20681800-20682800	Enhancers	Primary B cells from peripheral blood	blood
41	chr17:20682000-20682200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr17:20682200-20683400	Enhancers	Monocytes-CD14+_RO01746	blood
43	chr17:20682200-20687600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr17:20682600-20682800	Enhancers	Primary hematopoietic stem cells short term culture	blood
45	chr17:20683400-20684000	Weak transcription	Monocytes-CD14+_RO01746	blood
46	chr17:20683800-20684000	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr17:20684000-20684200	Enhancers	Monocytes-CD14+_RO01746	blood
48	chr17:20687200-20687800	Strong transcription	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr17:20687200-20688000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
50	chr17:20687400-20687600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links